Sign in
BRRGF Stock Price, Chart, Stats & News
BerGenBio ASA
Save
BerGenBio ASA (BRRGF) does not currently pay a dividend.
9.49B
Market cap
–
Current P/E
–
Forward P/E
BRRGF chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Biotechnology
Industry
BerGenBio ASA is a clinical-stage biopharmaceutical firm dedicated to discovering and advancing therapies for challenging conditions. This includes cancers that are immune-evasive, drug-resistant, or metastatic, as well as various respiratory diseases. Its leading drug candidate, Bemcentinib, is an orally available, small molecule AXL inhibitor that has progressed to Phase II clinical development.
Similar securities
Based on sector and market capitalization
Report issue